Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW856553 twice-daily placebo-controlled study in active rheumatoid arthritis
2006-001234-40Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing GW856553 with Placebo (2 arms). Primary endpoint: Disease Activity Score based on 28 joints. Started Jul 2006; status: completed.
02
Drugs
losmapimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-001234-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001234-40.